The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab as first-line treatment in patients with advanced colorectal cancer RAS/BRAF mutated (mut): NIVACOR trial (GOIRC-03-2018).
 
Angela Damato
No Relationships to Disclose
 
Francesca Bergamo
No Relationships to Disclose
 
Lorenzo Antonuzzo
No Relationships to Disclose
 
Guglielmo Nasti
No Relationships to Disclose
 
Filippo Pietrantonio
No Relationships to Disclose
 
Giuseppe Tonini
No Relationships to Disclose
 
Evaristo Maiello
No Relationships to Disclose
 
Roberto Bordonaro
No Relationships to Disclose
 
Gerardo Rosati
No Relationships to Disclose
 
Alessandra Romagnani
No Relationships to Disclose
 
Francesco Iachetta
No Relationships to Disclose
 
Mario Larocca
No Relationships to Disclose
 
Giuseppe Maglietta
No Relationships to Disclose
 
Nicola Normanno
No Relationships to Disclose
 
Carmine Pinto
No Relationships to Disclose